Amundi Xencor Inc Transaction History
Amundi
- $275 Billion
- Q1 2025
A detailed history of Amundi transactions in Xencor Inc stock. As of the latest transaction made, Amundi holds 28,318 shares of XNCR stock, worth $230,508. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,318
Previous 35,380
19.96%
Holding current value
$230,508
Previous $813,000
62.98%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding XNCR
# of Institutions
211Shares Held
78.4MCall Options Held
3.4KPut Options Held
1.9K-
Black Rock Inc. New York, NY11.1MShares$90.4 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.76MShares$79.5 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$64.3 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$50 Million5.14% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$32 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $486M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...